Characterizing vaginal misoprostol induction in individuals with and without severe obesity.

In 30 seconds

This secondary analysis of the vaginal misoprostol arm of a cluster-randomized trial compared term inductions in individuals with BMI < 40 versus ≥ 40 kg/m². Among 1,322 participants, those with severe obesity had longer inductions after adjustment for clustering, initial cervical dilation, hypertension, and diabetes: total duration was longer by an adjusted mean 3.5h (95% CI 1.9-4.8). They also required more misoprostol doses and had lower odds of vaginal delivery. The analysis reports associations between BMI group and induction outcomes; it did not randomize participants by BMI.

Key findings

• Severe obesity was associated with a 3.5h longer total induction duration (adjusted mean difference, 95% CI 1.9-4.8).
• First-stage labor was longer by an adjusted mean 2.2h (95% CI 0.6-3.8) in the BMI ≥ 40 kg/m² group.
• Oxytocin use lasted longer by an adjusted mean 2.5 (95% CI 1.1-3.8) in the severe-obesity group.
• BMI ≥ 40 kg/m² was associated with lower odds of vaginal delivery (aOR 0.6, 95% CI 0.4-0.8) and greater misoprostol dose requirements.

Why it matters

Induction may take longer and require more medication in individuals with severe obesity, while vaginal delivery is less likely in this analysis. These differences can inform expectations and counseling about the course of induction. The findings also highlight that any consideration of alternative protocols must be weighed against the comorbidities and obstetric morbidity noted in this population.

What to keep in mind

This was a secondary analysis comparing BMI groups, not a trial randomizing participants by BMI; the reported associations do not establish that severe obesity caused the differences.